(Q35990853)

11 August 2017

1 reference

title

Strategies for minimizing immunosuppression in kidney transplantation (English)

1 reference

11 August 2017

1 reference

kidney transplantation

1 reference

Allan D Kirk

1

1 reference

11 August 2017

Roslyn B Mannon

series ordinal

2

1 reference

11 August 2017

S John Swanson

series ordinal

3

1 reference

11 August 2017

Douglas A Hale

series ordinal

4

1 reference

11 August 2017

1 January 2005

1 reference

11 August 2017

Transplant International

1 reference

11 August 2017

18

1 reference

11 August 2017

1

1 reference

11 August 2017

2-14

1 reference

Infection in organ-transplant recipients

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Crossing the bridge: large animal models in translational transplantation research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Tolerogenic immunosuppression for organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Innate immune responses to transplants: a significant variable with cadaver donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Humoral theory of transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

In remembrance of things past: memory T cells and transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Heterologous immunity: an overlooked barrier to tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

New concepts in cyclosporine monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Long-term survival in renal transplant recipients with graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

The relationship between donor age and cadaveric renal allograft survival is modified by the recipient's blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Hospitalizations for cytomegalovirus disease after renal transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Human polyoma virus-associated interstitial nephritis in the allograft kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Polyomavirus Allograft Nephropathy: Sequential Assessment of Histologic Viral Load, Tubulitis, and Graft Function Following Changes in Immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Clinical course of polyoma virus nephropathy in 67 renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Polyomavirus nephropathy: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Long-term graft survival with neoral and tacrolimus: a paired kidney analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Six-year clinical effect of donor bone marrow infusions in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00019.X

10.1111/J.1432-2277.2004.00019.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference